GlobalData on MSN1d
Abcuro secures $200m as it eyes approval for rare muscle disease drug
The funding will be used to complete the Phase II/III trial of ulviprubart, and to support commercial launch preparation.
Healio3d
Silica dust, heavy metal, solvents may contribute to myositis with lung involvement
Exposures to silica dust, solvents or heavy metals increase the likelihood of developing various forms of myositis, ...
Hosted on MSN1mon
Hina Khan Reveals “Samantha Has Time & Again Checked On Me” During Cancer Fight Despite Her Personal Myositis Battle
She acknowledged that many people have been supportive during her cancer journey but Samantha ... During Cancer Fight Despite Her Personal Myositis Battle ...
Medscape15d
Certain Antibodies Predict Myositis Better Than Others
The positive predictive value (PPV) of myositis antibodies for diagnosing myositis and its related conditions differs by individual antibody type. Greater diagnostic accuracy is associated with ...
Nature5y
Engineering viral cancer killers
Oncolytic viruses have been used to treat cancer for more than 100 years ... it also causes respiratory-tract infections and myositis (inflammation and necrosis of muscle tissue).
PipelineReview.com2d
Abcuro Announces $200 Million Series C Financing to Advance Its First-In-Class Medicine in Development for Inclusion Body Myositis
NEWTON, MA, USA I 12, 2025 I Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and ...